| ID Source | ID |
|---|---|
| PubMed CID | 124851 |
| SCHEMBL ID | 4289308 |
| MeSH ID | M0195829 |
| Synonym |
|---|
| m-maleimidobenzoyl-n-hydroxysulfosuccinimide ester |
| 1-[3-(2,5-dioxopyrrol-1-yl)benzoyl]oxy-2,5-dioxopyrrolidine-3-sulfonic acid |
| 92921-25-0 |
| 1-((3-(2,5-dihydro-2,5-dioxo-1h-pyrrol-1-yl)benzoyl)oxy)-2,5-dioxo-3-pyrrolidinesulfonic acid |
| sulpho-mbs |
| m-maleimidobenzoyl-n-hydroxysulphosuccinimide ester |
| 3-pyrrolidinesulfonic acid, 1-((3-(2,5-dihydro-2,5-dioxo-1h-pyrrol-1-yl)benzoyl)oxy)-2,5-dioxo- |
| 103848-62-0 |
| SCHEMBL4289308 |
| sulfo-mbs crosslinker |
| 3-maleimidobenzoyl-n-hydroxysulphosuccinimide ester sodium salt |
| 3-maleimidobenzoic acid n-hydroxysulfosuccinimide ester |
| DIYPCWKHSODVAP-UHFFFAOYSA-N |
| 1-{[3-(2,5-dioxo-2,5-dihydro-1h-pyrrol-1-yl)benzoyl]oxy}-2,5-dioxopyrrolidine-3-sulfonic acid |
| DTXSID60908634 |
| sulfo-mbs cross linker |
| sulfo-mbs cross-linker |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (42.86) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.61) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 14 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||